NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim

NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine... Support Care Cancer (2018) 26:1323–1334 https://doi.org/10.1007/s00520-017-3959-2 ORIGINAL ARTICLE NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim 1 2 3 4 5 Jeffrey J. Kirshner & Maxwell C. McDonald III & Flavio Kruter & Andrew S. Guinigundo & Linda Vanni & 6 7 7 7,8 7 Cathy L. Maxwell & Maureen Reiner & Terry E. Upchurch & Jacob Garcia & Phuong Khanh Morrow Received: 20 March 2017 /Accepted: 3 November 2017 /Published online: 16 November 2017 The Author(s) 2017. This article is an open access publication Abstract pain. The primary endpoint was all-grade bone pain in Purpose Mild-to-moderate bone pain is a commonly reported cycle 1 from AE reporting. Secondary endpoints included adverse event (AE) associated with pegfilgrastim. We evalu- bone pain in cycles 2–4 and across all cycles from AE ated the effect of prophylactic naproxen or loratadine vs no reporting and patient-reported bone pain by cycle and prophylactic treatment on pegfilgrastim-associated bone pain. across all cycles. Methods In this open-label study (NCT01712009), wom- Results Six hundred patients were enrolled. Most patients en ≥ 18 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Supportive Care in Cancer Springer Journals

NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim

Loading next page...
 
/lp/springer_journal/nolan-a-randomized-phase-2-study-to-estimate-the-effect-of-Rnkc1krGOG
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Oncology; Nursing; Nursing Research; Pain Medicine; Rehabilitation Medicine
ISSN
0941-4355
eISSN
1433-7339
D.O.I.
10.1007/s00520-017-3959-2
Publisher site
See Article on Publisher Site

Abstract

Support Care Cancer (2018) 26:1323–1334 https://doi.org/10.1007/s00520-017-3959-2 ORIGINAL ARTICLE NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim 1 2 3 4 5 Jeffrey J. Kirshner & Maxwell C. McDonald III & Flavio Kruter & Andrew S. Guinigundo & Linda Vanni & 6 7 7 7,8 7 Cathy L. Maxwell & Maureen Reiner & Terry E. Upchurch & Jacob Garcia & Phuong Khanh Morrow Received: 20 March 2017 /Accepted: 3 November 2017 /Published online: 16 November 2017 The Author(s) 2017. This article is an open access publication Abstract pain. The primary endpoint was all-grade bone pain in Purpose Mild-to-moderate bone pain is a commonly reported cycle 1 from AE reporting. Secondary endpoints included adverse event (AE) associated with pegfilgrastim. We evalu- bone pain in cycles 2–4 and across all cycles from AE ated the effect of prophylactic naproxen or loratadine vs no reporting and patient-reported bone pain by cycle and prophylactic treatment on pegfilgrastim-associated bone pain. across all cycles. Methods In this open-label study (NCT01712009), wom- Results Six hundred patients were enrolled. Most patients en ≥ 18

Journal

Supportive Care in CancerSpringer Journals

Published: Nov 16, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off